YELLOW JACKET VENOM ALLERGENS, HYALURONIDASE AND PHOSPHOLIPASE - SEQUENCE SIMILARITY AND ANTIGENIC CROSS-REACTIVITY WITH THEIR HORNET AND WASP HOMOLOGS AND POSSIBLE IMPLICATIONS FOR CLINICAL ALLERGY

Citation
Tp. King et al., YELLOW JACKET VENOM ALLERGENS, HYALURONIDASE AND PHOSPHOLIPASE - SEQUENCE SIMILARITY AND ANTIGENIC CROSS-REACTIVITY WITH THEIR HORNET AND WASP HOMOLOGS AND POSSIBLE IMPLICATIONS FOR CLINICAL ALLERGY, Journal of allergy and clinical immunology, 98(3), 1996, pp. 588-600
Citations number
30
Categorie Soggetti
Immunology,Allergy
ISSN journal
00916749
Volume
98
Issue
3
Year of publication
1996
Pages
588 - 600
Database
ISI
SICI code
0091-6749(1996)98:3<588:YJVAHA>2.0.ZU;2-B
Abstract
Three known allergens of yellow jacket (Vespula vulgaris) venom are an tigen 5, hyaluronidase, and phospholipase. Yellow jacket antigen 5 has been previously cloned and expressed in bacteria; it contains 204 ami no acid residues, and it has 69% and 60% sequence identities with the homologous proteins of white-faced hornet (Dolichovespula maculata) an d wasp (Polistes annularis), respectively. These studies are now exten ded to yellow jacket hyaluronidase and phospholipase; they contain 331 and 300 amino acid residues, respectively, and they show 92% and 67% sequence identity with their homologs of white-faced hornet. Tests wit h the natural and the recombinant vespid allergens in mice indicate pa rtial antigenic cross-reactivity of their homologous proteins at both B- and T-cell levels. There is greater cross-reactivity among hornet a nd yellow jacket allergens than that among hornet or yellow jacket and wasp allergens. The order of cross-reaction of the three vespid aller gens is hyaluronidase > antigen 5 > phospholipase. The continuous (lin ear) B-cell epitopes of vespid allergens show greater cross-reactivity than their discontinuous epitopes do. The discontinuous B-cell epitop es are immunodominant for all vespid allergens. The low degree of cros s-reactivity of the immunodominant discontinuous B-cell epitopes of ve spid allergens should be taken into consideration in selection of veno ms for immunotherapy of patients with sensitivity to multiple vespids.